You have 9 free searches left this month | for more free features.

Metastatic melanoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

Active, not recruiting
  • Tumor Skin
  • +2 more
  • OBX-115
  • Orlando, Florida
  • +1 more
Sep 28, 2023

Melanoma Trial (ABP 206, Nivolumab)

Not yet recruiting
  • Melanoma
  • (no location specified)
Sep 20, 2023

Baseline Metastases on Clinical Outcomes Among BRAF Positive

Completed
  • BRAF Positive Metastatic Melanoma
    • East Hanover, New Jersey
      Novartis
    Aug 2, 2023

    Healthcare Resource Utilization and Costs in Metastatic Melanoma

    Terminated
    • Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis Investigational Site
      Apr 27, 2023

      Immunotherapy in Patients With Metastatic Melanoma

      Not yet recruiting
      • Metastatic Melanoma
      • data collection
      • (no location specified)
      Nov 28, 2022

      Associated Factors, and Clinical Outcomes of Prescribing

      Completed
      • BRAF v600 Mutated Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Mar 28, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

        Not yet recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +4 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Feb 28, 2023

        Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

        Not yet recruiting
        • Metastatic Melanoma
        • Head and Neck Squamous Cell Carcinoma
        • Portland, Oregon
          Providence Portland Medical Center
        Jun 19, 2023

        Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

        Not yet recruiting
        • Advanced Melanoma
        • Metastatic Melanoma
        • Memory-like natural killer cells
        • +2 more
        • Saint Louis, Missouri
          Washington University School of Medicine
        Nov 16, 2022

        Unresectable Melanoma, Metastatic Melanoma Trial in Brussel, Amsterdam, Barcelona (NEO-PTC-01)

        Recruiting
        • Unresectable Melanoma
        • Metastatic Melanoma
        • NEO-PTC-01
        • Brussel, Belgium
        • +2 more
        Dec 5, 2022

        Metastatic Melanoma Trial in Tampa (procedure, drug, other)

        Active, not recruiting
        • Metastatic Melanoma
        • Surgery
        • +3 more
        • Tampa, Florida
          H. Lee Moffitt Cancer Center & Research Institute
        Jan 10, 2023

        Metastatic Melanoma Trial in Marseille (PET with 18F-FDOPA)

        Completed
        • Metastatic Melanoma
        • PET with 18F-FDOPA
        • Marseille, France
          Assistance Publique Hopitaux de Marseille
        Nov 9, 2022

        Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

        Not yet recruiting
        • Metastatic Melanoma
        • +2 more
        • Lifileucel plus Pembrolizumab
        • Pembrolizumab with Optional Crossover Period
        • (no location specified)
        Feb 13, 2023

        Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)

        Completed
        • Metastatic Melanoma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 21, 2022

        Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

        Completed
        • Metastatic Melanoma
        • East Hanover, New Jersey
          Novartis Investigative Site
        Nov 11, 2022

        ive is Encorafenib Plus Binimetinib in Real-world and Clinical

        Not yet recruiting
        • Metastatic Melanoma
        • (no location specified)
        Jul 12, 2023

        Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

        Active, not recruiting
        • Melanoma and Other Malignant Neoplasms of Skin
        • Metastatic Melanoma
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Oct 31, 2022

        Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

        Recruiting
        • Clinical Stage IV Cutaneous Melanoma AJCC v8
        • +3 more
        • Scottsdale, Arizona
        • +2 more
        Jan 4, 2023

        Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

        Active, not recruiting
        • Metastatic
        • +4 more
        • Radiotherapy
        • +2 more
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Jan 6, 2023

        Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

        Not yet recruiting
        • Clinical Stage IV Cutaneous Melanoma AJCC v8
        • +4 more
        • Aerosol Sargramostim
        • +5 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 30, 2023

        Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

        Recruiting
        • Metastatic Melanoma
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 20, 2022

        Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

        Not yet recruiting
        • Recurrent Metastatic Melanoma
        • +3 more
        • Boston, Massachusetts
        • +1 more
        Jul 29, 2022

        Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

        Recruiting
        • Uveal Melanoma
        • +3 more
        • Lifileucel (LN-144)
        • Harrison, New York
        • +1 more
        Nov 8, 2022

        Tumor, Metastatic Melanoma, Melanoma Trial in Houston (OBX-115, Acetazolamide, Cyclophosphamide)

        Not yet recruiting
        • Tumor
        • +2 more
        • Houston, Texas
          MD Anderson Cancer Center
        Aug 16, 2022